Supplementary Figure 4 Supplementary Figure S5 . Predicted secondary structures of U1utr and U1utr_stb. The secondary structure of U1utr according to a previous report (32) (middle) and the secondary structures of U1utr (left) and U1utr_stb (right) predicted by CentroidFold software. The predicted secondary structure of U1utr (left) was different from the reported structure (middle). In contrast, stabilized U1utr_stb had a similar structure to the reported structure (right). Small letters in U1utr_stb represent the nucleotides changed from the original U1utr to stabilize the stem regions. Purple shadows represent U1A recognition sequences. Color scale represents base pairing probabilities calculated by CentroidFold software.
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Reported secondary structure To show the generality of our design approach, we engineered alternative protein-responsive mRNA devices using an in vitro selected aptamer. We chose nuclear factor-κB (NF-κB) p50 protein and the in vitro selected p50 aptamer (p50A). NF-κB is a major transcription factor and is involved in a variety of cellular responses including cell proliferation and cancer (53, 54) . The p50 domain is composed of the amino acids 39-352 of human NF-κB and its aptamer, p50A, has been reported previously (14, 55) . To increase the stability of p50A, we engineered the aptamer with a longer stem region (Supplementary Figure S8A ; termed p50A-stb) and inserted it into the 5'-UTR of the EGFP reporter plasmid. After co-transfection of the reporter EGFP with p50A-stb and the p50-expressing trigger plasmids, we observed clear translational repression (approximately 60% repression, Supplementary Figure S8B , C) whereas the reporter with the original p50A or defective mutant (p50A-stb mut ) did not repress translation in the presence of p50 and maintained similar translation level compared with the control reporter (no aptamer). The results indicate that our approach can be applied to not only naturally occurring RNA motifs but also in vitro selected aptamers to generate functional mRNA devices in living cells. U n t r a n s f e c t e d m 5 C / ψ N a t i v e p o l y I C U n t r e a t e d U n t r a n s f e c t e d m 5 C / ψ N a t i v e p o l y I C U n t r e a t e d Tables   Supplementary Table S1 DNA oligo sets for constructing device plasmids. 
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